Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Suzhou, Jiangsu, People's Republic of China.
Shenzhen Lifotronic Technology Co., Ltd, 1008 Songbai Road, Shenzhen, Guangdong, People's Republic of China.
Luminescence. 2020 Mar;35(2):215-221. doi: 10.1002/bio.3716. Epub 2019 Dec 18.
Although the clinical use of immunoassays based on the oxidative-reduction electrochemiluminescence (ECL) of tris(2,2'-bipyridine)ruthenium (II)/tri-n-propylamine has been a great success, elucidation of the ECL generation mechanism still remains unsatisfactory. We report here our experimental observations of long-lived luminescence that remains detectable for several seconds after termination of electrochemical heterogeneous oxidation. Long-lived luminescence was observed in both a surfactant-free buffer and a surfactant-containing broadly used commercial buffer under different conditions. The slow decay of emission seems to have been unnoticed in previous ECL mechanistic studies. Within the frame of the reaction schemes so far proposed, its origin is inconclusively ascribed to the reductive-oxidation process of ruthenium (II) complex, that is Ru(bpy) → Ru(bpy) → Ru(bpy) * → Ru(bpy) with the involvement of the tri-n-propylamine-derived radical cation. It is anticipated that long-lived ECL will suggest a research approach to separate some homogeneous reactions from the complicated reaction system and therefore help to resolve the mechanistic mystery.
虽然基于三(2,2'-联吡啶)钌(II)/三正丙胺的氧化还原电化学发光(ECL)的免疫分析在临床上已经取得了巨大的成功,但其 ECL 产生机制的阐明仍然不尽如人意。我们在这里报告了我们的实验观察结果,即在电化学异相氧化终止后,仍可检测到数秒长的发光。在不同条件下,在无表面活性剂缓冲液和含有广泛使用的商业缓冲液的表面活性剂缓冲液中都观察到了长寿命发光。在以前的 ECL 机理研究中,似乎没有注意到发射的缓慢衰减。在迄今为止提出的反应方案框架内,其起源被不确定地归因于钌(II)配合物的还原-氧化过程,即 Ru(bpy) → Ru(bpy) → Ru(bpy) * → Ru(bpy) ,涉及三正丙胺衍生的自由基阳离子。预计长寿命 ECL 将提出一种研究方法,将一些均相反应与复杂的反应体系分离,从而有助于解决机理之谜。